10 results on '"Grange, L."'
Search Results
2. Human chondrocytes, reactive oxygen species production and Nox
- Author
-
Grange, L, Stasia, MJ, Vergnaud, S, Lu, JS, Trocme, C, Gaudin, P, and Morel, F
- Subjects
Meeting Abstract - Published
- 2003
3. Revealing potential functions of hypothetical proteins induced by genistein in the symbiosis island of Bradyrhizobium japonicum commercial strain SEMIA 5079 (= CPAC 15).
- Author
-
Ferreira EGC, Gomes DF, Delai CV, Barreiros MAB, Grange L, Rodrigues EP, Henning LMM, Barcellos FG, and Hungria M
- Subjects
- Genistein metabolism, Genistein pharmacology, Genomic Islands, Nitrogen Fixation genetics, Glycine max genetics, Symbiosis genetics, Bradyrhizobium genetics, Bradyrhizobium metabolism
- Abstract
Background: Bradyrhizobium japonicum strain SEMIA 5079 (= CPAC 15) is a nitrogen-fixing symbiont of soybean broadly used in commercial inoculants in Brazil. Its genome has about 50% of hypothetical (HP) protein-coding genes, many in the symbiosis island, raising questions about their putative role on the biological nitrogen fixation (BNF) process. This study aimed to infer functional roles to 15 HP genes localized in the symbiosis island of SEMIA 5079, and to analyze their expression in the presence of a nod-gene inducer., Results: A workflow of bioinformatics tools/databases was established and allowed the functional annotation of the HP genes. Most were enzymes, including transferases in the biosynthetic pathways of cobalamin, amino acids and secondary metabolites that may help in saprophytic ability and stress tolerance, and hydrolases, that may be important for competitiveness, plant infection, and stress tolerance. Putative roles for other enzymes and transporters identified are discussed. Some HP proteins were specific to the genus Bradyrhizobium, others to specific host legumes, and the analysis of orthologues helped to predict roles in BNF., Conclusions: All 15 HP genes were induced by genistein and high induction was confirmed in five of them, suggesting major roles in the BNF process., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
4. Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes.
- Author
-
Beghain J, Langlois AC, Legrand E, Grange L, Khim N, Witkowski B, Duru V, Ma L, Bouchier C, Ménard D, Paul RE, and Ariey F
- Subjects
- Cambodia, Cytochromes b genetics, Genomics, Haploidy, Multidrug Resistance-Associated Proteins genetics, Real-Time Polymerase Chain Reaction, DNA Copy Number Variations, Genome, Protozoan, Plasmodium genetics, Protozoan Proteins genetics
- Abstract
Background: In eukaryotic genomes, deletion or amplification rates have been estimated to be a thousand more frequent than single nucleotide variation. In Plasmodium falciparum, relatively few transcription factors have been identified, and the regulation of transcription is seemingly largely influenced by gene amplification events. Thus copy number variation (CNV) is a major mechanism enabling parasite genomes to adapt to new environmental changes., Methods: Currently, the detection of CNVs is based on quantitative PCR (qPCR), which is significantly limited by the relatively small number of genes that can be analysed at any one time. Technological advances that facilitate whole-genome sequencing, such as next generation sequencing (NGS) enable deeper analyses of the genomic variation to be performed. Because the characteristics of Plasmodium CNVs need special consideration in algorithms and strategies for which classical CNV detection programs are not suited a dedicated algorithm to detect CNVs across the entire exome of P. falciparum was developed. This algorithm is based on a custom read depth strategy through NGS data and called PlasmoCNVScan., Results: The analysis of CNV identification on three genes known to have different levels of amplification and which are located either in the nuclear, apicoplast or mitochondrial genomes is presented. The results are correlated with the qPCR experiments, usually used for identification of locus specific amplification/deletion., Conclusions: This tool will facilitate the study of P. falciparum genomic adaptation in response to ecological changes: drug pressure, decreased transmission, reduction of the parasite population size (transition to pre-elimination endemic area).
- Published
- 2016
- Full Text
- View/download PDF
5. Filter-free exhaustive odds ratio-based genome-wide interaction approach pinpoints evidence for interaction in the HLA region in psoriasis.
- Author
-
Grange L, Bureau JF, Nikolayeva I, Paul R, Van Steen K, Schwikowski B, and Sakuntabhai A
- Subjects
- Chromosomes, Human, Pair 6, Humans, Odds Ratio, Polymorphism, Single Nucleotide, Epistasis, Genetic, Genome-Wide Association Study methods, Histocompatibility Antigens genetics, Psoriasis genetics, Software
- Abstract
Background: Deciphering the genetic architecture of complex traits is still a major challenge for human genetics. In most cases, genome-wide association studies have only partially explained the heritability of traits and diseases. Epistasis, one potentially important cause of this missing heritability, is difficult to explore at the genome-wide level. Here, we develop and assess a tool based on interactive odds ratios (IOR), Fast Odds Ratio-based sCan for Epistasis (FORCE), as a novel approach for exhaustive genome-wide epistasis search. IOR is the ratio between the multiplicative term of the odds ratio (OR) of having each variant over the OR of having both of them. By definition, an IOR that significantly deviates from 1 suggests the occurrence of an interaction (epistasis). As the IOR is fast to calculate, we used the IOR to rank and select pairs of interacting polymorphisms for P value estimation, which is more time consuming., Results: FORCE displayed power and accuracy similar to existing parametric and non-parametric methods, and is fast enough to complete a filter-free genome-wide epistasis search in a few days on a standard computer. Analysis of psoriasis data uncovered novel epistatic interactions in the HLA region, corroborating the known major and complex role of the HLA region in psoriasis susceptibility., Conclusions: Our systematic study revealed the ability of FORCE to uncover novel interactions, highlighted the importance of exhaustiveness, as well as its specificity for certain types of interactions that were not detected by existing approaches. We therefore believe that FORCE is a valuable new tool for decoding the genetic basis of complex diseases.
- Published
- 2015
- Full Text
- View/download PDF
6. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study.
- Author
-
Dahab M, Charalambous S, Karstaedt AS, Fielding KL, Hamilton R, La Grange L, Churchyard GJ, and Grant AD
- Subjects
- Adult, Cohort Studies, Female, Forecasting, Humans, Male, Middle Aged, Patient Compliance, South Africa, Surveys and Questionnaires, Anti-Retroviral Agents therapeutic use, HIV Infections drug therapy, Health Promotion, Outcome Assessment, Health Care
- Abstract
Background: Many national antiretroviral therapy (ART) programmes encourage providers to identify and address baseline factors associated with poor treatment outcomes, including modifiable adherence-related behaviours, before initiating ART. However, evidence on such predictors is scarce, and providers judgement may often be inaccurate. To help address this evidence gap, this observational cohort study examined baseline factors potentially predictive of poor treatment outcomes in two ART programmes in South Africa, with a particular focus on determinants of adherence., Methods: Treatment-naïve patients starting ART were enrolled from a community and a workplace ART programme. Potential baseline predictors associated with poor treatment outcomes (defined as viral load > 400 copies/ml or having discontinued treatment by six months) were assessed using logistic regression. Exposure variables were organised for regression analysis using a hierarchical framework., Results: 38/227 (17%) of participants in the community had poor treatment outcomes compared to 47/117 (40%) in the workplace. In the community, predictors of worse outcomes included: drinking more than 20 units of alcohol per week, having no prior experience of chronic medications, and consulting a traditional healer in the past year (adjusted odds ratio [aOR] 15.36, 95% CI 3.22-73.27; aOR 2.30, 95%CI 1.00-5.30; aOR 2.27, 95% CI 1.00-5.19 respectively). Being male and knowing someone on ART were associated with better outcomes (aOR 0.25, 95%CI 0.09-0.74; aOR 0.44, 95%CI 0.19-1.01 respectively). In the workplace, predictors of poor treatment outcomes included being uncertain about the health effects of ART and a traditional healer's ability to treat HIV (aOR 7.53, 95%CI 2.02-27.98; aOR 4.40, 95%CI 1.41-13.75 respectively). Longer pre-ART waiting time (2-12 weeks compared to <2 weeks) predicted better treatment outcomes (aOR 0.13, 95% CI 0.03-0.56)., Conclusion: Baseline predictors of poor treatment outcomes were largely unique to each programme, likely reflecting different populations and pathways to HIV care. In the workplace, active promotion of HIV testing may have extended ART to individuals who, without provider initiation, would not have spontaneously sought care. As provider-initiated testing makes ART available to individuals less motivated to seek care, patients may need additional adherence support, especially addressing uncertainty about the health benefits of ART.
- Published
- 2010
- Full Text
- View/download PDF
7. A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.
- Author
-
Marotte H, Pallot-Prades B, Grange L, Gaudin P, Alexandre C, and Miossec P
- Subjects
- Absorptiometry, Photon, Case-Control Studies, Drug Resistance, Drug Therapy, Combination, Female, Humans, Immunosuppressive Agents therapeutic use, Infliximab, Male, Methotrexate therapeutic use, Osteocalcin blood, Parathyroid Hormone blood, Anti-Inflammatory Agents therapeutic use, Antibodies, Monoclonal therapeutic use, Arthritis, Rheumatoid drug therapy, Bone Density drug effects
- Abstract
The goal of the present study was to record changes in bone mineral density (BMD) and markers of bone turnover in patients with rheumatoid arthritis (RA) who were treated with methotrexate combined (or not combined) with infliximab. Included were 90 patients with RA who required anti-TNF-alpha therapy with infliximab because of persistent active disease despite treatment with methotrexate. The historical control group included 99 patients with RA who were treated with methotrexate at a time when anti-TNF-alpha treatment was not yet available. Lumbar and femoral neck BMD was measured using dual energy X-ray absorptiometry at baseline and 1 year later. Osteocalcin, C-terminal cross-linked telopeptide of type I collagen, parathyroid hormone and 25-hydroxycholecalciferol were measured in plasma at baseline and 1 year later. At 1 year BMD had decreased in the control group at spine (P < 0.01) and femoral neck (P < 0.001). In contrast, BMD at spine and femoral neck did not change after 1 year of infliximab treatment. At the same time point, no change in bone remodelling markers was observed. No association was observed between clinical response and changes in BMD, indicating that even those who did not respond clinically did not lose bone over a 1-year period. These data confirm the BMD decrease observed in RA patients treated with methotrexate alone. This bone loss was prevented by infliximab therapy. Importantly, this beneficial effect was also observed in apparent nonresponders.
- Published
- 2007
- Full Text
- View/download PDF
8. Local hyperemia to heating is impaired in secondary Raynaud's phenomenon.
- Author
-
Boignard A, Salvat-Melis M, Carpentier PH, Minson CT, Grange L, Duc C, Sarrot-Reynauld F, and Cracowski JL
- Subjects
- Adult, Cell Count, Cohort Studies, Endothelium, Vascular drug effects, Endothelium, Vascular physiopathology, Female, Fingers blood supply, Humans, Kinetics, Laser-Doppler Flowmetry, Male, Middle Aged, Models, Biological, Nitric Oxide physiology, Nitroglycerin, ROC Curve, Raynaud Disease etiology, Reproducibility of Results, Scleroderma, Diffuse physiopathology, Stem Cells pathology, Tourniquets, Vasodilation drug effects, Vasodilator Agents, Hot Temperature, Hyperemia physiopathology, Raynaud Disease physiopathology, Scleroderma, Diffuse complications
- Abstract
Accurate and sensitive measurement techniques are a key issue in the quantification of the microvascular and endothelial dysfunction in systemic sclerosis (SSc). Thermal hyperemia comprises two separate mechanisms: an initial peak that is axon reflex mediated; and a sustained plateau phase that is nitric oxide dependent. The main objective of our study was to test whether thermal hyperemia in patients with SSc differed from that in patients with primary Raynaud's phenomenon (RP) and healthy controls. In a first study, we enrolled 20 patients suffering from SSc, 20 patients with primary RP and 20 healthy volunteers. All subjects were in a fasting state. Post-occlusive hyperemia, 0.4 mg sublingual nitroglycerin challenge and thermal hyperemia were performed using laser Doppler flowmetry on the distal pad of the third left finger. In a second study, thermal hyperemia was performed in 10 patients with rheumatoid arthritis and 10 patients with primary RP. The thermal hyperemia was dramatically altered in terms of amplitude and kinetics in patients with SSc. Whereas 19 healthy volunteers and 18 patients with primary RP exhibited the classic response, including an initial peak within the first 10 minutes followed by a nadir and a second peak, this occurred only in four of the SSc patients (p < 0.0001). The 10 minutes thermal peak was 43.4 (23.2 to 63), 42.6 (31 to 80.7) and 27 (14.7 to 51.4) mV/mm Hg in the healthy volunteers, primary RP and SSc groups, respectively (p = 0.01), while the 44 degrees C thermal peak was 43.1 (21.3 to 62.1), 42.6 (31.6 to 74.3) and 25.4 (15 to 52.4) mV/mm Hg, respectively (p = 0.01). Thermal hyperemia was more sensitive and specific than post-occlusive hyperhemia for differentiating SSc from primary RP. In patients with rheumatoid arthritis, thermal hyperemia was also altered in terms of amplitude. Thermal hyperemia is dramatically altered in patients with secondary RP in comparison with subjects with primary RP. Further studies are required to determine the mechanisms of this altered response, and whether it may provide additional information in a clinical setting.
- Published
- 2005
- Full Text
- View/download PDF
9. The effects of ethanol and silymarin treatment during gestation on spatial working memory.
- Author
-
Neese S, La Grange L, Trujillo E, and Romero D
- Subjects
- Animals, Birth Weight drug effects, Brain pathology, Female, Fetal Alcohol Spectrum Disorders prevention & control, Male, Organ Size drug effects, Pregnancy, Rats, Rats, Inbred F344, Ethanol toxicity, Memory drug effects, Prenatal Exposure Delayed Effects, Protective Agents pharmacology, Silymarin pharmacology, Space Perception drug effects
- Abstract
Background: Using a rat model we have found that the bioflavonoid silymarin (SY) ameliorates some of the negative consequences of in utero exposure to ethanol (EtOH). In the current study our aim was to determine if spatial working memory (SWM) was impaired in offspring whose mothers were maintained on a liquid diet containing EtOH during different gestational weeks. We also determined if SWM was altered with a concomitant administration of SY with EtOH during specific gestational weeks., Methods: We provided pregnant Fischer/344 rats with liquid diets containing 35% EtOH derived calories (EDC) during specific weeks of the gestational period. A silymarin/phospholipid compound containing 29.8% silybin co-administered with EtOH was also administered during specific weeks of the gestational period. We tested SWM of the offspring with a radial arm maze on postnatal day (PND) 60. After testing the rats were sacrificed and their brains perfused for later analysis., Results: We observed SWM deficits, as well as a significantly lower brain weight in female offspring born of mothers treated with EtOH during the third week of gestation in comparison to mothers treated during either the first or second weeks of gestation. Rats from any group receiving EtOH in co-administration with SY showed no significant deficits in SWM., Conclusion: EtOH treatment during the last week of gestation had the greatest impact on SWM. The addition of SY to the EtOH liquid diet appeared to ameliorate the EtOH-induced learning deficits.
- Published
- 2004
- Full Text
- View/download PDF
10. Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin.
- Author
-
Moreland N, La Grange L, and Montoya R
- Subjects
- Agenesis of Corpus Callosum, Analysis of Variance, Animals, Body Weight drug effects, Brain pathology, Corpus Callosum drug effects, Corpus Callosum embryology, Corpus Callosum pathology, Female, Fetal Alcohol Spectrum Disorders drug therapy, Fetal Alcohol Spectrum Disorders physiopathology, Organ Size drug effects, Pregnancy, Rats, Rats, Inbred F344, Silybin, Corpus Callosum growth & development, Ethanol toxicity, Functional Laterality drug effects, Prenatal Exposure Delayed Effects, Protective Agents pharmacology, Silymarin pharmacology
- Abstract
Background: Using a rat model we have found that the bioflavonoid silymarin (SY) ameliorates some of the negative consequences of in utero exposure to ethanol (EtOH). In the current study our aim was to determine if laterality preference and corpus callosum development were altered in rat offspring whose mothers were provided with a concomitant administration of SY with EtOH throughout gestation., Methods: We provided pregnant Fisher/344 rats with liquid diets containing 35% ethanol derived calories (EDC) throughout the gestational period. A silymarin/phospholipid compound containing 29.8% silybin was co administered with EtOH to a separate experimental group. We tested the offspring for laterality preference at age 12 weeks. After testing the rats were sacrificed and their brains perfused for later corpus callosum extraction., Results: We observed incomplete development of the splenium in the EtOH-only offspring. Callosal development was complete in all other treatment groups. Rats from the EtOH-only group displayed a left paw preference; whereas control rats were evenly divided between right and left paw preference. Inexplicably both SY groups were largely right paw preferring., Conclusions: The addition of SY to the EtOH liquid diet did confer some ameliorative effects upon the developing fetal rat brain.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.